Increased levels of 4-hydroxynonenal and acrolein in the brain in preclinical Alzheimer disease

Neuropathological stageing of Alzheimer-related changes.

Braak, H., & Braak, E. (1991) · Acta Neuropathologica · doi:10.1007/bf00308809 · Cited by 16,123 · see citing works

Chemistry and biochemistry of 4-hydroxynonenal, malonaldehyde and related aldehydes

Esterbauer, H., Schaur, R. J., & Zollner, H. (1991) · Free Radical Biology and Medicine · doi:10.1016/0891-5849(91)90192-6 · Cited by 6,672 · see citing works

Oxidative Damage Is the Earliest Event in Alzheimer Disease

Nunomura, A., Perry, G., Aliev, G., Hirai, K., Takeda, A., Balraj, E. K., Jones, P. K., Ghanbari, H., Wataya, T., Shimohama, S., et al. (2001) · Journal of Neuropathology & Experimental Neurology · doi:10.1093/jnen/60.8.759 · Cited by 1,885 · see citing works

Analysis of enzymatically amplified β-globin and HLA-DQα DNA with allele-specific oligonucleotide probes

Saiki, R. K., Bugawan, T. L., Horn, G. T., Mullis, K. B., & Erlich, H. A. (1986) · Nature · doi:10.1038/324163a0 · Cited by 1,826 · see citing works

4-Hydroxy-2-nonenal: a product and mediator of oxidative stress

Uchida, K. (2003) · Progress in Lipid Research · doi:10.1016/s0163-7827(03)00014-6 · Cited by 1,164 · see citing works

Oxidative damage to mitochondrial DNA is increased in Alzheimer’s disease

Mecocci, P., MacGarvey, U., & Beal, M. F. (1994) · Annals of Neurology · doi:10.1002/ana.410360510 · Cited by 1,037 · see citing works

RNA Oxidation Is a Prominent Feature of Vulnerable Neurons in Alzheimer’s Disease

Nunomura, A., Perry, G., Pappolla, M., Wade, R., Hirai, K., Chiba, S., & Smith, M. A. (1999) · Journal of Neuroscience · doi:10.1523/jneurosci.19-06-01959.1999 · Cited by 768 · see citing works

Lipid peroxidation of membrane phospholipids generates hydroxy-alkenals and oxidized phospholipids active in physiological and/or pathological conditions

Catalá, A. (2009) · Chemistry and Physics of Lipids · doi:10.1016/j.chemphyslip.2008.09.004 · Cited by 745 · see citing works

Four-hydroxynonenal, a product of lipid peroxidation, is increased in the brain in Alzheimer's disease

Markesbery, W. R., & Lovell, M. A. (1998) · Neurobiology of Aging · doi:10.1016/s0197-4580(98)00009-8 · Cited by 680 · see citing works

Fatty acid composition of brain phospholipids in aging and in Alzheimer’s disease

Söderberg, M., Edlund, C., Kristensson, K., & Dallner, G. (1991) · Lipids · doi:10.1007/bf02536067 · Cited by 667 · see citing works

Acrolein Is a Product of Lipid Peroxidation Reaction

Uchida, K., Kanematsu, M., Morimitsu, Y., Osawa, T., Noguchi, N., & Niki, E. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.26.16058 · Cited by 546 · see citing works

Increased Nuclear DNA Oxidation in the Brain in Alzheimer's Disease

Gabbita, S. P., Lovell, M. A., & Markesbery, W. R. (1998) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1998.71052034.x · Cited by 479 · see citing works

Acrolein is increased in Alzheimer’s disease brain and is toxic to primary hippocampal cultures

Lovell, M. A., Xie, C., & Markesbery, W. R. (2001) · Neurobiology of Aging · doi:10.1016/s0197-4580(00)00235-9 · Cited by 449 · see citing works

Regional Membrane Phospholipid Alterations in Alzheimer's Disease

Prasad, M. R., Lovell, M. A., Yatin, M., Dhillon, H. S., & Markesbery, W. R. (1998) · Neurochemical Research · doi:10.1023/a:1022457605436 · Cited by 440 · see citing works

Ribosome Dysfunction Is an Early Event in Alzheimer's Disease

Ding, Q., Markesbery, W. R., Chen, Q., Li, F., & Keller, J. N. (2005) · The Journal of Neuroscience · doi:10.1523/jneurosci.3040-05.2005 · Cited by 433 · see citing works

Protein‐Bound Acrolein

Calingasan, N. Y., Uchida, K., & Gibson, G. E. (1999) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1999.0720751.x · Cited by 400 · see citing works

Increased levels of 4-hydroxynonenal and acrolein, neurotoxic markers of lipid peroxidation, in the brain in Mild Cognitive Impairment and early Alzheimer's disease

Williams, T. I., Lynn, B. C., Markesbery, W. R., & Lovell, M. A. (2005) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2005.06.004 · Cited by 391 · see citing works

Redox proteomics identification of oxidatively modified hippocampal proteins in mild cognitive impairment: Insights into the development of Alzheimer's disease

Butterfield, D. A., Poon, H. F., St. Clair, D., Keller, J. N., Pierce, W. M., Klein, J. B., & Markesbery, W. R. (2006) · Neurobiology of Disease · doi:10.1016/j.nbd.2005.11.002 · Cited by 377 · see citing works

“Preclinical” AD revisited: Neuropathology of cognitively normal older adults

Schmitt, F. A., Davis, D. G., Wekstein, D. R., Smith, C. D., Ashford, J. W., & Markesbery, W. R. (2000) · Neurology · doi:10.1212/wnl.55.3.370 · Cited by 369 · see citing works

Increased DNA Oxidation and Decreased Levels of Repair Products in Alzheimer's Disease Ventricular CSF

Lovell, M. A., Gabbita, S. P., & Markesbery, W. R. (1999) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1999.0720771.x · Cited by 291 · see citing works

Decreased glutathione transferase activity in brain and ventricular fluid in Alzheimer's disease

Lovell, M. A., Xie, C., & Markesbery, W. R. (1998) · Neurology · doi:10.1212/wnl.51.6.1562 · Cited by 275 · see citing works

Lipid peroxidation is an early event in the brain in amnestic mild cognitive impairment

Markesbery, W. R., Kryscio, R. J., Lovell, M. A., & Morrow, J. D. (2005) · Annals of Neurology · doi:10.1002/ana.20629 · Cited by 272 · see citing works

Increased oxidative damage in nuclear and mitochondrial DNA in mild cognitive impairment

Wang, J., Markesbery, W. R., & Lovell, M. A. (2006) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2005.03615.x · Cited by 260 · see citing works

Decrease in Peptide Methionine Sulfoxide Reductase in Alzheimer's Disease Brain

Gabbita, S. P., Aksenov, M. Y., Lovell, M. A., & Markesbery, W. R. (1999) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1999.0731660.x · Cited by 256 · see citing works

Oxidative modification and down-regulation of Pin1 in Alzheimer's disease hippocampus: A redox proteomics analysis

Rukhsana Sultana, A., Debra Boyd-kimball, A., Poon, H. F., Cai, J., Pierce, W. M. J., Klein, J. B., Markesbery, W. R., Zhou, X. Z., Lu, K. P., & Butterfield, D. A. (2005) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2005.05.005 · Cited by 255 · see citing works

Increased oxidative stress in Alzheimer's disease as assessed with 4-hydroxynonenal but not malondialdehyde

McGrath, L. T. (2001) · QJM · doi:10.1093/qjmed/94.9.485 · Cited by 253 · see citing works

Elevated protein-bound levels of the lipid peroxidation product, 4-hydroxy-2-nonenal, in brain from persons with mild cognitive impairment

Butterfield, D. A., Reed, T., Perluigi, M., De Marco, C., Coccia, R., Cini, C., & Sultana, R. (2006) · Neuroscience Letters · doi:10.1016/j.neulet.2005.12.017 · Cited by 246 · see citing works

Immunohistochemical detection of 4-hydroxy-2-nonenal adducts in Alzheimer's disease is associated with inheritance of APOE4.

Montine, K. S., Olson, S. J., Amarnath, K., Whetsell, W. O., Graham, D. G., & Montine, T. J. (1997) · Europe PMC (PubMed Central) · Cited by 220 · see citing works

The Identification and Characterization of Oxidized RNAs in Alzheimer's Disease

Shan, X., Tashiro, H., & Lin, C. G. (2003) · Journal of Neuroscience · doi:10.1523/jneurosci.23-12-04913.2003 · Cited by 185 · see citing works

Brain Regional Quantification of F-Ring and D-/E-Ring Isoprostanes and Neuroprostanes in Alzheimer’s Disease

Reich, E. E., Markesbery, W. R., Roberts, L. J., Swift, L. L., Morrow, J. D., & Montine, T. J. (2001) · American Journal Of Pathology · doi:10.1016/s0002-9440(10)63968-5 · Cited by 183 · see citing works

4-Hydroxynonenal, a product of lipid peroxidation, inhibits dephosphorylation of the microtubule-associated protein tau

Mattson, M. P., Fu, W., Waeg, G., & Uchida, K. (1997) · NeuroReport · doi:10.1097/00001756-199707070-00036 · Cited by 176 · see citing works

Decreased base excision repair and increased helicase activity in Alzheimer's disease brain

Lovell, M. A., Xie, C., & Markesbery, W. R. (2000) · Brain Research · doi:10.1016/s0006-8993(99)02335-5 · Cited by 174 · see citing works

Packing and Viscoelasticity of Polyunsaturated ω-3 and ω-6 Lipid Bilayers as Seen by 2H NMR and X-ray Diffraction

Rajamoorthi, K., Petrache, H. I., McIntosh, T. J., & Brown, M. F. (2005) · Journal of the American Chemical Society · doi:10.1021/ja046453b · Cited by 144 · see citing works

Decreased RNA, and Increased RNA Oxidation, in Ribosomes from Early Alzheimer’s Disease

Ding, Q., Markesbery, W. R., Cecarini, V., & Keller, J. N. (2006) · Neurochemical Research · doi:10.1007/s11064-006-9071-5 · Cited by 140 · see citing works

Acrolein, a product of lipid peroxidation, inhibits glucose and glutamate uptake in primary neuronal cultures

Lovell, M. A., Xie, C., & Markesbery, W. R. (2000) · Free Radical Biology and Medicine · doi:10.1016/s0891-5849(00)00346-4 · Cited by 127 · see citing works

Altered 8-oxoguanine glycosylase in mild cognitive impairment and late-stage Alzheimer’s disease brain

Shao, C., Xiong, S., Li, G.-M., Gu, L., Mao, G., Markesbery, W. R., & Lovell, M. A. (2008) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2008.06.003 · Cited by 114 · see citing works

Acrolein inhibits NADH-linked mitochondrial enzyme activity: Implications for Alzheimer's disease

Pocernich, C. B., & Butterfield, D. A. (2003) · Neurotoxicity Research · doi:10.1007/bf03033161 · Cited by 113 · see citing works

Levels of 4-Hydroxynonenal and Malondialdehyde Are Increased in Brain of Human Chronic Users of Methamphetamine

Fitzmaurice, P. S., Tong, J., Yazdanpanah, M., Liu, P. P., Kalasinsky, K. S., & Kish, S. J. (2006) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.106.109173 · Cited by 89 · see citing works

4-Hydroxynonenal oxidatively modifies histones: implications for Alzheimer's disease

Drake, J., Petroze, R. T., Castegna, A., Ding, Q., Keller, J. N., Markesbery, W. R., Lovell, M. A., & Butterfield, D. A. (2004) · Neuroscience Letters · doi:10.1016/j.neulet.2003.11.047 · Cited by 77 · see citing works

Formation of Nɛ-(succinyl)lysine in vivo: a novel marker for docosahexaenoic acid-derived protein modification

Kawai, Y., Fujii, H., Okada, M., Tsuchie, Y., Uchida, K., & Osawa, T. (2006) · Journal of Lipid Research · doi:10.1194/jlr.m600091-jlr200 · Cited by 53 · see citing works

Improved predictive model for pre-symptomatic mild cognitive impairment and Alzheimer's disease

Smith, C. D., Chebrolu, H., Markesbery, W. R., & Liu, J. (2008) · Neurological Research · doi:10.1179/174313208x327973 · Cited by 10 · see citing works

Oxidative stress, dysfunctional glucose metabolism and Alzheimer disease

Butterfield, D. A., & Halliwell, B. (2019) · Nature Reviews Neuroscience · doi:10.1038/s41583-019-0132-6 · Cited by 1,954 · see citing works

Lipid peroxidation and neurodegenerative disease

Reed, T. T. (2011) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2011.06.027 · Cited by 380 · see citing works

Brain iron is associated with accelerated cognitive decline in people with Alzheimer pathology

Ayton, S., Wang, Y., Diouf, I., Schneider, J. A., Brockman, J. D., Morris, M. C., & Bush, A. I. (2019) · Molecular Psychiatry · doi:10.1038/s41380-019-0375-7 · Cited by 372 · see citing works

Alteration of mTOR signaling occurs early in the progression of Alzheimer disease (AD): analysis of brain from subjects with pre‐clinical AD, amnestic mild cognitive impairment and late‐stage AD

Tramutola, A., Triplett, J. C., Di Domenico, F., Niedowicz, D. M., Murphy, M. P., Coccia, R., Perluigi, M., & Butterfield, D. A. (2015) · Journal of Neurochemistry · doi:10.1111/jnc.13037 · Cited by 347 · see citing works

Role of Monoamine Oxidase Activity in Alzheimer’s Disease: An Insight into the Therapeutic Potential of Inhibitors

Behl, T., Kaur, D., Sehgal, A., Singh, S., Sharma, N., Zengin, G., Andronie-Cioară, F. L., Toma, M. M., BUNGAU, S. G., & Bumbu, A. G. (2021) · Molecules · doi:10.3390/molecules26123724 · Cited by 333 · see citing works

Oxidative stress, protein modification and Alzheimer disease

Tramutola, A., Lanzillotta, C., Perluigi, M., & Butterfield, D. A. (2017) · Brain Research Bulletin · doi:10.1016/j.brainresbull.2016.06.005 · Cited by 303 · see citing works

Alzheimer’s disease: pathological mechanisms and the beneficial role of melatonin

Rosales‐Corral, S., Acuña-Castroviejo, D., Coto‐Montes, A. M., Boga, J. A., Manchester, L. C., Fuentes‐Broto, L., Korkmaz, A., Ma, S., Tan, D. X., & Reiter, R. J. (2011) · Journal of Pineal Research · doi:10.1111/j.1600-079x.2011.00937.x · Cited by 293 · see citing works

4-Hydroxy-2-nonenal: a critical target in oxidative stress?

Breitzig, M., Bhimineni, C., Lockey, R. F., & Kolliputi, N. (2016) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00101.2016 · Cited by 284 · see citing works

Caffeic Acid and Diseases—Mechanisms of Action

Pavlíková, N. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms24010588 · Cited by 265 · see citing works

Common and Novel Markers for Measuring Inflammation and Oxidative Stress Ex Vivo in Research and Clinical Practice—Which to Use Regarding Disease Outcomes?

Menzel, A., Samouda, H., Dohet, F., Loap, S., Ellulu, M. S., & Bohn, T. (2021) · Antioxidants · doi:10.3390/antiox10030414 · Cited by 222 · see citing works

Epigenetic changes in the progression of Alzheimer's disease

Bradley‐Whitman, M. A., & Lovell, M. A. (2013) · Mechanisms of Ageing and Development · doi:10.1016/j.mad.2013.08.005 · Cited by 193 · see citing works

Biomarkers of lipid peroxidation in Alzheimer disease (AD): an update

Bradley‐Whitman, M. A., & Lovell, M. A. (2015) · Archives of Toxicology · doi:10.1007/s00204-015-1517-6 · Cited by 192 · see citing works

Biomaterial Scaffold Fabrication Techniques for Potential Tissue Engineering Applications

Subia, B., Kundu, S. C., & C., S. (2010) · InTech eBooks · doi:10.5772/8581 · Cited by 187 · see citing works

Oxidative Damage to RNA in Aging and Neurodegenerative Disorders

Nunomura, A., Moreira, P. I., Castellani, R. J., Lee, H., Zhu, X., Smith, M. A., & Perry, G. L. (2012) · Neurotoxicity Research · doi:10.1007/s12640-012-9331-x · Cited by 183 · see citing works

Oxidative stress in Alzheimer disease and mild cognitive impairment: evidence from human data provided by redox proteomics

Swomley, A. M., & Butterfield, D. A. (2015) · Archives of Toxicology · doi:10.1007/s00204-015-1556-z · Cited by 171 · see citing works

Redox Proteomics in Selected Neurodegenerative Disorders: From Its Infancy to Future Applications

Butterfield, D. A., Marzia Perluigi, A., Reed, T. T., Muharib, T., Hughes, C. P., Robinson, R. A. S., & Rukhsana Sultana, A. (2011) · Antioxidants and Redox Signaling · doi:10.1089/ars.2011.4109 · Cited by 167 · see citing works

Regional brain iron associated with deterioration in Alzheimer's disease: A large cohort study and theoretical significance

Ayton, S., Portbury, S. D., Kalinowski, P., Agarwal, P., Diouf, I., Schneider, J. A., Morris, M. C., & Bush, A. I. (2021) · Alzheimer s & Dementia · doi:10.1002/alz.12282 · Cited by 168 · see citing works

Role of By-Products of Lipid Oxidation in Alzheimer's Disease Brain: A Focus on Acrolein

Singh, M., Nam, D. T., Arseneault, M., & Ramassamy, C. (2010) · Journal of Alzheimer s Disease · doi:10.3233/jad-2010-100405 · Cited by 162 · see citing works

Pharmacological Inhibition of Ferroptosis as a Therapeutic Target for Neurodegenerative Diseases and Strokes

Wang, Y., Wu, S., Li, Q., Sun, H., & Wang, H. (2023) · Advanced Science · doi:10.1002/advs.202300325 · Cited by 161 · see citing works

Roles of Oxidative Stress in Synaptic Dysfunction and Neuronal Cell Death in Alzheimer’s Disease

Plascencia‐Villa, G., & Perry, G. L. (2023) · Antioxidants · doi:10.3390/antiox12081628 · Cited by 167 · see citing works

Lipoxidation in cardiovascular diseases

Gianazza, E., Brioschi, M., Fernandez, A. M., & Banfi, C. (2019) · Redox Biology · doi:10.1016/j.redox.2019.101119 · Cited by 152 · see citing works

Neuroprotective effects of anthocyanins and its major component cyanidin-3-O-glucoside (C3G) in the central nervous system: An outlined review

Zhang, J., Wu, J., Liu, F., Tong, L., Chen, Z., Chen, J., He, H., Xu, R., Ma, Y., & Huang, C. (2019) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2019.172500 · Cited by 147 · see citing works

Connecting the “Dots”: From Free Radical Lipid Autoxidation to Cell Pathology and Disease

Foret, M. K., Lincoln, R., Carmo, S. D., Cuello, A. C., & Cosa, G. (2020) · Chemical Reviews · doi:10.1021/acs.chemrev.0c00761 · Cited by 144 · see citing works

Lipid Peroxidation and Its Toxicological Implications

Nam, T. G. (2011) · Toxicological Research · doi:10.5487/tr.2011.27.1.001 · Cited by 144 · see citing works

DNA polymerase β deficiency leads to neurodegeneration and exacerbates Alzheimer disease phenotypes

Sýkora, P., Misiak, M., Wang, Y., Ghosh, S., Leandro, G. D. S., Liu, D., Tian, J. Y., Baptiste, B. A., Cong, W., Brenerman, B. M., et al. (2014) · Nucleic Acids Research · doi:10.1093/nar/gku1356 · Cited by 136 · see citing works

Cellular Stress Responses, Mitostress and Carnitine Insufficiencies as Critical Determinants in Aging and Neurodegenerative Disorders: Role of Hormesis and Vitagenes

Calabrese, V., Cornelius, C., Stella, A. M. G., & Calabrese, E. J. (2010) · Neurochemical Research · doi:10.1007/s11064-010-0307-z · Cited by 134 · see citing works

Amyloid-β Toxicity and Tau Hyperphosphorylation are Linked Via RCAN1 in Alzheimer's Disease

Lloret, A., Badía, M.-C., Giraldo, E., Ermak, G., Alonso, M.-D., Pallardó, F. V., Davies, K. J. A., & Viña, J. (2011) · Journal of Alzheimer s Disease · doi:10.3233/jad-2011-110890 · Cited by 133 · see citing works

CMS121, a fatty acid synthase inhibitor, protects against excess lipid peroxidation and inflammation and alleviates cognitive loss in a transgenic mouse model of Alzheimer's disease

Ates, G., Goldberg, J., Currais, A. J. M., & Maher, P. A. (2020) · Redox Biology · doi:10.1016/j.redox.2020.101648 · Cited by 131 · see citing works

The Earliest Stage of Cognitive Impairment in Transition From Normal Aging to Alzheimer Disease Is Marked by Prominent RNA Oxidation in Vulnerable Neurons

Nunomura, A., Tamaoki, T., Motohashi, N., Nakamura, M., McKeel, D. W., Tabaton, M., Lee, H., Smith, M. A., Perry, G. L., & Zhu, X. (2012) · Journal of Neuropathology & Experimental Neurology · doi:10.1097/nen.0b013e318248e614 · Cited by 131 · see citing works

The 2013 SFRBM Discovery Award: Selected discoveries from the Butterfield laboratory of oxidative stress and its sequela in brain in cognitive disorders exemplified by Alzheimer disease and chemotherapy induced cognitive impairment

Butterfield, D. A. (2014) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2014.06.006 · Cited by 126 · see citing works

Oxidatively modified nucleic acids in preclinical Alzheimer's disease (PCAD) brain

Lovell, M. A., Soman, S., & Bradley, M. A. (2011) · Mechanisms of Ageing and Development · doi:10.1016/j.mad.2011.08.003 · Cited by 124 · see citing works

Cellular, synaptic, and biochemical features of resilient cognition in Alzheimer’s disease

Arnold, S. E., Louneva, N., Cao, K., Wang, L.-S., Han, L.-Y., Wolk, D. A., Negash, S., Leurgans, S. E., Schneider, J. A., Buchman, A. S., et al. (2013) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2012.03.004 · Cited by 123 · see citing works

Lipid Peroxidation and Antioxidant Supplementation in Neurodegenerative Diseases: A Review of Human Studies

Petrović, S., Arsić, A., Ristić-Medić, D., Cvetković, Z., & Vučić, V. (2020) · Antioxidants · doi:10.3390/antiox9111128 · Cited by 122 · see citing works

Pharmacodynamic effects and molecular mechanisms of lignans from Schisandra chinensis Turcz. (Baill.), a current review

Zhou, Y., Men, L., Sun, Y., Wei, M., & Fan, X. (2020) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2020.173796 · Cited by 117 · see citing works

Advance of sporadic Alzheimer's disease animal models

Zhang, L., Chen, C., Mak, M. S., Lu, J., Wu, Z., Chen, Q., Han, Y., Li, Y., & Pi, R. (2020) · Medicinal Research Reviews · doi:10.1002/med.21624 · Cited by 116 · see citing works

Apolipoprotein E potently inhibits ferroptosis by blocking ferritinophagy

Belaidi, A. A., Masaldan, S., Southon, A. G., Kalinowski, P., Acevedo, K. M., Appukuttan, A. T., Portbury, S. D., Lei, P., Agarwal, P., Leurgans, S. E., et al. (2022) · Molecular Psychiatry · doi:10.1038/s41380-022-01568-w · Cited by 116 · see citing works

4-hydroxynonenal-mediated signaling and aging

Zhang, H., & Forman, H. J. (2017) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2016.11.032 · Cited by 114 · see citing works

Phosphodiesterase Inhibitors for Alzheimer’s Disease: A Systematic Review of Clinical Trials and Epidemiology with a Mechanistic Rationale

Sanders, O. D., & Rajagopal, L. (2020) · Journal of Alzheimer s Disease Reports · doi:10.3233/adr-200191 · Cited by 115 · see citing works

Interaction of Cinnamaldehyde and Epicatechin with Tau: Implications of Beneficial Effects in Modulating Alzheimer's Disease Pathogenesis

George, R. C., Lew, J., & Graves, D. J. (2013) · Journal of Alzheimer s Disease · doi:10.3233/jad-122113 · Cited by 112 · see citing works

Nucleic acid oxidation: an early feature of Alzheimer's disease

Bradley‐Whitman, M. A., Timmons, M. D., Beckett, T. L., Murphy, M. P., Lynn, B. C., & Lovell, M. A. (2014) · Journal of Neurochemistry · doi:10.1111/jnc.12444 · Cited by 112 · see citing works

Exploring the Effect of Phyllanthus emblica L. on Cognitive Performance, Brain Antioxidant Markers and Acetylcholinesterase Activity in Rats: Promising Natural Gift for the Mitigation of Alzheimer's Disease

Uddin, M. S., Mamun, A. A., Hossain, M. S., Akter, F., Iqbal, M. A., & Asaduzzaman, M. (2016) · Annals of Neurosciences · doi:10.1159/000449482 · Cited by 109 · see citing works

Acrolein Disrupts Tight Junction Proteins and Causes Endoplasmic Reticulum Stress-Mediated Epithelial Cell Death Leading to Intestinal Barrier Dysfunction and Permeability

Chen, W.-Y., Wang, M., Zhang, J., Barve, S. S., McClain, C. J., & Joshi‐Barve, S. (2017) · American Journal Of Pathology · doi:10.1016/j.ajpath.2017.08.015 · Cited by 109 · see citing works

Acrolein Exposure in U.S. Tobacco Smokers and Non-Tobacco Users: NHANES 2005–2006

Alwis, K. U., deCastro, B. R., Morrow, J. C., & Blount, B. C. (2015) · Environmental Health Perspectives · doi:10.1289/ehp.1409251 · Cited by 108 · see citing works

Treating Alzheimer's disease by targeting iron

Nikseresht, S., Bush, A. I., & Ayton, S. (2019) · British Journal of Pharmacology · doi:10.1111/bph.14567 · Cited by 98 · see citing works

Redox proteomics analysis of brains from subjects with amnestic mild cognitive impairment compared to brains from subjects with preclinical Alzheimer’s disease: Insights into memory loss in MCI

Aluise, C. D., Robinson, R. A. S., Cai, J., Pierce, W. M., Markesbery, W. R., & Butterfield, D. A. (2011) · Journal of Alzheimer's Disease · doi:10.3233/jad-2010-101083 · Cited by 94 · see citing works

Deuterated polyunsaturated fatty acids reduce brain lipid peroxidation and hippocampal amyloid β-peptide levels, without discernable behavioral effects in an APP/PS1 mutant transgenic mouse model of Alzheimer's disease

Raefsky, S. M., Furman, R., Milne, G., Pollock, E., Axelsen, P., Mattson, M. P., & Shchepinov, M. S. (2018) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2018.02.024 · Cited by 90 · see citing works

Elevated 4-hydroxyhexenal in Alzheimer's disease (AD) progression

Bradley‐Whitman, M. A., Xiong, S., Markesbery, W. R., & Lovell, M. A. (2010) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2010.08.016 · Cited by 90 · see citing works

Contribution of the HNE-immunohistochemistry to modern pathological concepts of major human diseases

Žarković, K., Jakovčević, A., & Žarković, N. (2016) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2016.12.009 · Cited by 87 · see citing works

Protective effects of caffeic acid and caffeic acid phenethyl ester against acrolein-induced neurotoxicity in HT22 mouse hippocampal cells

Huang, Y., Jin, M., Pi, R., Zhang, J., Chen, M., Ouyang, Y., Liu, A., Chao, X., Liu, P., Liu, J., et al. (2013) · Neuroscience Letters · doi:10.1016/j.neulet.2012.12.051 · Cited by 87 · see citing works

Acrolein induces Alzheimer's disease-like pathologies in vitro and in vivo

Huang, Y., Jin, M.-H., Pi, R., Zhang, J., Ouyang, Y., Chao, X., Chen, M.-H., Liu, P., Yu, J., Ramassamy, C., et al. (2013) · Toxicology Letters · doi:10.1016/j.toxlet.2012.12.023 · Cited by 88 · see citing works

Iron Dysregulation in Mitochondrial Dysfunction and Alzheimer’s Disease

Onukwufor, J. O., Dirksen, R. T., & Wojtovich, A. P. (2022) · Antioxidants · doi:10.3390/antiox11040692 · Cited by 83 · see citing works

High-fat diet induces changes in adipose tissue trans-4-oxo-2-nonenal and trans-4-hydroxy-2-nonenal levels in a depot-specific manner

Long, E. K., Olson, D. M., & Bernlohr, D. (2013) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2013.05.030 · Cited by 83 · see citing works

Preclinical Alzheimer disease: Brain oxidative stress, Aβ peptide and proteomics

Aluise, C. D., Sowell, R. A., Beckett, T. L., Murphy, M. P., Cai, J., Pierce, W. M. J., Markesbery, W. R., & Butterfield, D. A. (2010) · Neurobiology of Disease · doi:10.1016/j.nbd.2010.04.011 · Cited by 83 · see citing works

Overlapped Metabolic and Therapeutic Links between Alzheimer and Diabetes

Ahmad, W. (2012) · Molecular Neurobiology · doi:10.1007/s12035-012-8352-z · Cited by 80 · see citing works

Sildenafil for the Treatment of Alzheimer’s Disease: A Systematic Review

Sanders, O. D. (2020) · Journal of Alzheimer s Disease Reports · doi:10.3233/adr-200166 · Cited by 76 · see citing works

Yin-Yang Mechanisms Regulating Lipid Peroxidation of Docosahexaenoic Acid and Arachidonic Acid in the Central Nervous System

Yang, B., Fritsche, K. L., Beversdorf, D. Q., Gu, Z., Lee, J. C., Folk, W. R., Greenlief, C. M., & Sun, G. Y. (2019) · Frontiers in Neurology · doi:10.3389/fneur.2019.00642 · Cited by 74 · see citing works

Redox proteomics identification of specifically carbonylated proteins in the hippocampi of triple transgenic Alzheimer’s disease mice at its earliest pathological stage

Shen, L., Chen, C., Yang, A., Chen, Y., Liu, Q., & Ni, J. (2015) · Journal of Proteomics · doi:10.1016/j.jprot.2015.04.005 · Cited by 73 · see citing works

Brain infarction correlates more closely with acrolein than with reactive oxygen species

Saiki, R., Park, H., Ishii, I., Yoshida, M., Nishimura, K., Toida, T., Tatsukawa, H., Kojima, S., Ikeguchi, Y., Pegg, A. E., et al. (2010) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2010.12.107 · Cited by 72 · see citing works

The Potential Role of Ferroptosis in Alzheimer’s Disease

Zhang, G., Zhang, Y.-R., Shen, Y., Wang, Y., Zhao, M. L., & Sun, L. (2021) · Journal of Alzheimer s Disease · doi:10.3233/jad-201369 · Cited by 69 · see citing works

Systemic Oxidative Stress in Older Patients with Mild Cognitive Impairment or Late Onset Alzheimer's Disease

Cervellati, C., Cremonini, E., Bosi, C., Magon, S., Zurlo, A., Bergamini, C. M., & Zuliani, G. (2013) · Current Alzheimer Research · doi:10.2174/1567205011310040003 · Cited by 70 · see citing works

Mitochondria as a Source and a Target for Uremic Toxins

Popkov, V. A., Silachev, D. N., Zalevsky, A. O., Zorov, D. B., & Plotnikov, E. Y. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20123094 · Cited by 62 · see citing works

Protein‐conjugated acrolein as a biochemical marker of brain infarction

Igarashi, K., & Kashiwagi, K. (2011) · Molecular Nutrition & Food Research · doi:10.1002/mnfr.201100068 · Cited by 60 · see citing works

Testosterone depletion increases the susceptibility of brain tissue to oxidative damage in a restraint stress mouse model

Son, S., Lee, J., Kim, H.-G., Kim, D. W., Ahn, Y., & Son, C. (2015) · Journal of Neurochemistry · doi:10.1111/jnc.13371 · Cited by 59 · see citing works

Mitochondrial dysfunction in the APP/PSEN1 mouse model of Alzheimer’s disease and a novel protective role for ascorbate

Dixit, S., Fessel, J. P., & Harrison, F. E. (2017) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2017.08.021 · Cited by 58 · see citing works

Aldehyde dehydrogenase 2 in the spotlight: The link between mitochondria and neurodegeneration

Deza-Ponzio, R., Herrera, M. L., Bellini, M. J., Virgolini, M. B., & Hereñú, C. B. (2018) · NeuroToxicology · doi:10.1016/j.neuro.2018.06.005 · Cited by 58 · see citing works

Increased Protein-Conjugated Acrolein and Amyloid-β40/42 Ratio in Plasma of Patients with Mild Cognitive Impairment and Alzheimer's Disease

Waragai, M., Yoshida, M., Mizoi, M., Saiki, R., Kashiwagi, K., Takagi, K., Arai, H., Tashiro, J., Hashimoto, M., Iwai, N., et al. (2012) · Journal of Alzheimer s Disease · doi:10.3233/jad-2012-120253 · Cited by 56 · see citing works

Signaling by 4-hydroxy-2-nonenal: Exposure protocols, target selectivity and degradation

Zhang, H., & Forman, H. J. (2016) · Archives of Biochemistry and Biophysics · doi:10.1016/j.abb.2016.11.003 · Cited by 56 · see citing works

An Ammonium Bicarbonate-Enhanced Stable Isotope Dilution UHPLC-MS/MS Method for Sensitive and Accurate Quantification of Acrolein–DNA Adducts in Human Leukocytes

Yin, R., Liu, S., Zhao, C., Lü, M., Tang, M., & Wang, H. (2013) · Analytical Chemistry · doi:10.1021/ac3034695 · Cited by 55 · see citing works

Role of Lipid Peroxidation-Derivedα,β-Unsaturated Aldehydes in Vascular Dysfunction

Lee, S. E., & Park, Y. S. (2013) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2013/629028 · Cited by 54 · see citing works

Oxidative stress, antioxidant defense and depressive disorders: A systematic review of biochemical and molecular markers

Barbosa, M. L., de Menezes, A. P. M., de Aguiar, R. P. S., Sousa, J. M. D. C. E., Cavalcante, A. A. D. C. M., & Maluf, S. W. (2020) · Neurology Psychiatry and Brain Research · doi:10.1016/j.npbr.2020.02.006 · Cited by 54 · see citing works

Ferroptosis mechanism and Alzheimer's disease

Feng, L., Sun, J. J., Xia, L., Shi, Q., Hou, Y., Zhang, L., Li, M., Fan, C., & Sun, B. (2023) · Neural Regeneration Research · doi:10.4103/1673-5374.389362 · Cited by 54 · see citing works

Dietary lipids and their oxidized products in Alzheimer's disease

Corsinovi, L., Biasi, F., Poli, G., Leonarduzzi, G., & Isaia, G. (2011) · Molecular Nutrition & Food Research · doi:10.1002/mnfr.201100208 · Cited by 53 · see citing works

Curcumin protects neuronal‐like cells against acrolein by restoring A kt and redox signaling pathways

Doggui, S., Belkacemi, A., Paka, G. D., Perrotte, M., Pi, R., & Ramassamy, C. (2013) · Molecular Nutrition & Food Research · doi:10.1002/mnfr.201300130 · Cited by 51 · see citing works

Artemisinin inhibits neuronal ferroptosis in Alzheimer’s disease models by targeting KEAP1

Deng, P.-X., Silva, M., Yang, N., Wang, Q., Meng, X., Ye, K., Gao, H., & Zheng, W. (2024) · Acta Pharmacologica Sinica · doi:10.1038/s41401-024-01378-6 · Cited by 51 · see citing works

Chronic Apocynin Treatment Attenuates Beta Amyloid Plaque Size and Microglial Number in hAPP(751)SL Mice

Lull, M. E., Levesque, S., Surace, M. J., & Block, M. L. (2011) · PLoS ONE · doi:10.1371/journal.pone.0020153 · Cited by 51 · see citing works

Acrolein is involved in ischemic stroke-induced neurotoxicity through spermidine/spermine-N1-acetyltransferase activation

Liu, J., Wang, T.-W., Lin, Y., Ho, W.-C., Tsai, H., Chen, S., Lin, A. M.-Y., Liu, T., & Wang, H. (2019) · Experimental Neurology · doi:10.1016/j.expneurol.2019.113066 · Cited by 50 · see citing works

Proteolytic degradation of heat shock protein A2 occurs in response to oxidative stress in male germ cells of the mouse

Bromfield, E. G., Aitken, R. J., McLaughlin, E. A., & Nixon, B. (2016) · Molecular Human Reproduction · doi:10.1093/molehr/gaw074 · Cited by 47 · see citing works

Acrolein toxicity at advanced age: present and future

Igarashi, K., Uemura, T., & Kashiwagi, K. (2017) · Amino Acids · doi:10.1007/s00726-017-2527-x · Cited by 47 · see citing works

Alterations in Acrolein Metabolism Contribute to Alzheimer’s Disease

Tsou, H., Hsu, W.-C., Fuh, J., Chen, S., Liu, T., & Wang, H. (2017) · Journal of Alzheimer s Disease · doi:10.3233/jad-170736 · Cited by 47 · see citing works

Andrographolide Reduces Neuroinflammation and Oxidative Stress in Aged Octodon degus

Lindsay, C. B., Zolezzi, J. M., Rivera, D. S., Cisternas, P., Bozinovic, F., & Inestrosa, N. C. (2019) · Molecular Neurobiology · doi:10.1007/s12035-019-01784-6 · Cited by 47 · see citing works

Aldehyde dehydrogenase 2 protects against abdominal aortic aneurysm formation by reducing reactive oxygen species, vascular inflammation, and apoptosis of vascular smooth muscle cells

Tsai, S., Hsu, L., Tsai, H., Yeh, Y., Lu, C., Chen, P., Wang, J., Chiu, Y., Lin, C., & Hsu, Y. (2020) · The FASEB Journal · doi:10.1096/fj.201902550rrr · Cited by 47 · see citing works

Chronic oxidative damage together with genome repair deficiency in the neurons is a double whammy for neurodegeneration: Is damage response signaling a potential therapeutic target?

Wang, H., Dharmalingam, P., Vasquez, V., Mitra, J., Boldogh, I. R., Rao, K. S. J., Kent, T. A., MITRA, S. P., & Hegde, M. L. (2016) · Mechanisms of Ageing and Development · doi:10.1016/j.mad.2016.09.005 · Cited by 44 · see citing works

Potential role and therapeutic implications of glutathione peroxidase 4 in the treatment of Alzheimer’s disease

Shen, Y., Zhang, G., Wei, C., Zhao, P., Wang, Y., Li, M., & Sun, L. (2024) · Neural Regeneration Research · doi:10.4103/nrr.nrr-d-23-01343 · Cited by 44 · see citing works

Acrolein acts as a neurotoxin in the nigrostriatal dopaminergic system of rat: involvement of α-synuclein aggregation and programmed cell death

Wang, Y.-T., Lin, H., Zhao, W.-Z., Huang, H.-J., Lo, Y., Wang, H., & Lin, A. M. (2017) · Scientific Reports · doi:10.1038/srep45741 · Cited by 42 · see citing works

The Impact of Medium Chain and Polyunsaturated ω-3-Fatty Acids on Amyloid-β Deposition, Oxidative Stress and Metabolic Dysfunction Associated with Alzheimer’s Disease

Mett, J. (2021) · Antioxidants · doi:10.3390/antiox10121991 · Cited by 40 · see citing works

Ischemic stroke disrupts the endothelial glycocalyx through activation of proHPSE via acrolein exposure

Ko, K., Suzuki, T., Ishikawa, R., Hattori, N., Ito, R., Umehara, K., Furihata, T., Dohmae, N., Linhardt, R. J., Igarashi, K., et al. (2020) · Journal of Biological Chemistry · doi:10.1074/jbc.ra120.015105 · Cited by 42 · see citing works

Oxidative damage and amyloid‐β metabolism in brain regions of the longest‐lived rodents

Edrey, Y. H., Oddo, S., Cornelius, C., Caccamo, A., Calabrese, V., & Buffenstein, R. (2013) · Journal of Neuroscience Research · doi:10.1002/jnr.23320 · Cited by 39 · see citing works

Acrolein-conjugated low-density lipoprotein induces macrophage foam cell formation

Watanabe, K., Nakazato, Y., Saiki, R., Igarashi, K., Kitada, M., & Ishii, I. (2012) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2012.12.020 · Cited by 39 · see citing works

Guarana (Paullinia cupana Mart.) Prevents β‐Amyloid Aggregation, Generation of Advanced Glycation‐end Products (AGEs), and Acrolein‐Induced Cytotoxicity on Human Neuronal‐Like Cells

Bittencourt, L. D. S., Zeidán‐Chuliá, F., Yatsu, F. K. J., Schnorr, C. E., Moresco, K. S., Kolling, E. A., Gelain, D. P., Bassani, V. L., & Moreira, J. C. F. (2014) · Phytotherapy Research · doi:10.1002/ptr.5173 · Cited by 37 · see citing works

Mitochondrial dysfunction and cellular metabolic deficiency in Alzheimer’s disease

Gu, X., Huang, H., & Jiang, Z.-F. (2012) · Neuroscience Bulletin · doi:10.1007/s12264-012-1270-2 · Cited by 37 · see citing works

Augmented glutathione synthesis decreases acrolein toxicity

Tomitori, H., Nakamura, M., Sakamoto, A., Terui, Y., Yoshida, M., Igarashi, K., & Kashiwagi, K. (2012) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2011.12.143 · Cited by 37 · see citing works

In vitro screening of neuroprotective activity of Indian medicinal plant Withania somnifera

Singh, M., & Ramassamy, C. (2017) · Journal of Nutritional Science · doi:10.1017/jns.2017.48 · Cited by 37 · see citing works

Inactivation of GAPDH as one mechanism of acrolein toxicity

Nakamura, M., Tomitori, H., Suzuki, T., Sakamoto, A., Terui, Y., Saiki, R., Dohmae, N., Igarashi, K., & Kashiwagi, K. (2012) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2012.12.057 · Cited by 36 · see citing works

Distinction between mild cognitive impairment and Alzheimer's disease by CSF amyloid β40 and β42, and protein-conjugated acrolein

Mizoi, M., Yoshida, M., Saiki, R., Waragai, M., Uemura, K., Akatsu, H., Kashiwagi, K., & Igarashi, K. (2014) · Clinica Chimica Acta · doi:10.1016/j.cca.2014.01.007 · Cited by 36 · see citing works

Overview of the Neuroprotective Effects of the MAO-Inhibiting Antidepressant Phenelzine

Matveychuk, D., MacKenzie, E. M., Kumpula, D. J., Song, M.-S., Holt, A., Kar, S., Todd, K. G., Wood, P. L., & Baker, G. B. (2021) · Cellular and Molecular Neurobiology · doi:10.1007/s10571-021-01078-3 · Cited by 37 · see citing works

Evaluation of dementia by acrolein, amyloid-β and creatinine

Igarashi, K., Yoshida, M., Waragai, M., & Kashiwagi, K. (2015) · Clinica Chimica Acta · doi:10.1016/j.cca.2015.07.017 · Cited by 36 · see citing works

Lipid Mediators and Their Metabolism in the Nucleus: Implications for Alzheimer's Disease

Farooqui, A. A. (2012) · Journal of Alzheimer s Disease · doi:10.3233/jad-2011-111085 · Cited by 34 · see citing works

Inverse correlation between stroke and urinary 3-hydroxypropyl mercapturic acid, an acrolein-glutathione metabolite

Yoshida, M., Mikami, T., Higashi, K., Saiki, R., Mizoi, M., Fukuda, K., Nakamura, T., Ishii, I., Nishimura, K., Toida, T., et al. (2012) · Clinica Chimica Acta · doi:10.1016/j.cca.2012.01.020 · Cited by 34 · see citing works

Attenuation of the effects of oxidative stress by the MAO-inhibiting antidepressant and carbonyl scavenger phenelzine

Baker, G. B., Matveychuk, D., MacKenzie, E. M., Holt, A., Wang, Y., & Kar, S. (2019) · Chemico-Biological Interactions · doi:10.1016/j.cbi.2019.03.003 · Cited by 33 · see citing works

Reactive Aldehydes and Neurodegenerative Disorders

Matveychuk, D., Dursun, S. M., Wood, P. L., & Baker, G. B. (2011) · Klinik Psikofarmakoloji Bülteni-Bulletin of Clinical Psychopharmacology · doi:10.5455/bcp.19691231040000 · Cited by 33 · see citing works

Increased levels of 4-hydroxynonenal and acrolein, neurotoxic markers of lipid peroxidation, in the brain in Mild Cognitive Impairment and early Alzheimer's disease

Williams, T. I., Lynn, B. C., Markesbery, W. R., & Lovell, M. A. (2005) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2005.06.004 · Cited by 391 · see citing works

Acrolein is increased in Alzheimer’s disease brain and is toxic to primary hippocampal cultures

Lovell, M. A., Xie, C., & Markesbery, W. R. (2001) · Neurobiology of Aging · doi:10.1016/s0197-4580(00)00235-9 · Cited by 449 · see citing works

Elevated 4-hydroxyhexenal in Alzheimer's disease (AD) progression

Bradley‐Whitman, M. A., Xiong, S., Markesbery, W. R., & Lovell, M. A. (2010) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2010.08.016 · Cited by 90 · see citing works

Potential Role of Acrolein in Neurodegeneration and in Alzheimers Disease

Nam, D. T., Arseneault, M., Murthy, V., & Ramassamy, C. (2010) · Current Molecular Pharmacology · doi:10.2174/1874-470211003020066 · Cited by 97 · see citing works

Four-hydroxynonenal, a product of lipid peroxidation, is increased in the brain in Alzheimer's disease

Markesbery, W. R., & Lovell, M. A. (1998) · Neurobiology of Aging · doi:10.1016/s0197-4580(98)00009-8 · Cited by 680 · see citing works